DJIA 16,514.37 65.12 0.40%
NASDAQ 4,161.46 0.00 0.00%
S&P 500 1,879.55 7.66 0.41%
market minute promo

Biogen Idec

NASDAQ: BIIB

306.20 8.22 (2.76%)

REAL-TIME: Last trade at

Extended Hours: $311.08 $4.88 (1.59%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

BIIB $306.20 2.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $300.50
Previous Close $297.98
Daily Range $300.00 - $309.17
52-Week Range $194.66 - $358.89
Market Cap $72.4B
P/E Ratio 38.15
Dividend (Yield) $0.00 (0.0%)
Volume 1,777,115
Average Daily Volume 2,010,252
Current FY EPS $11.29

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

BIIB's Top Competitors

BIIB $306.20 (2.76%)
Current stock: BIIB
AMGN $119.30 (1.95%)
Current stock: AMGN
CELG $146.64 (1.95%)
Current stock: CELG
GILD $72.86 (1.76%)
Current stock: GILD